Friday, November 08, 2019 1:13:32 PM
Financing Activities
For the year ended December 31, 2018, the net cash provided by financing activities was $944,889 compared to $1,266,916 for the nine months ended December 31, 2017.
During the year ended December 31, 2018, we received proceeds of $1,067,000 from the issuance of convertible notes. The proceeds were used in operations and to pay $122,111 of convertible notes.
During the nine months ended December 31, 2017, we received proceeds of $2,020,030 from the issuance of convertible notes, and $17,801 for notes, related party. The proceeds were used in operations and to pay $328,662 of convertible notes, $328,162 of notes payable, $154,651 of notes payable related party, and $820 for a bank overdraft.
So where did the money go??????
BVTK has nothing to show for it except a blog that Tom writes that brings in no money or sales!!!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM